DiBiase Mary
X4 Pharmaceuticals, Inc. · Chief Operating Officer
DiBiase Mary is listed in filings as Chief Operating Officer at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 14, 2025, including sale activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Sep 11, 2024 to Feb 14, 2025. Reported amounts are shown as $10.1K to $1.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $10k22.3k shares | SellJan 24, 2025 | $0.4535 | $3.82 |